Table of Contents
• Postherpetic Neuralgia overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Postherpetic Neuralgia Market
• Global Epidemiology of Postherpetic Neuralgia Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Postherpetic Neuralgia Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Postherpetic Neuralgia (2013-2023)
• Table 7: Postherpetic Neuralgia Global Market (USD Millions), (2013-2015)
• Table 8: Postherpetic Neuralgia Global Market (USD Millions), (2016-2023)
• Table 9: Postherpetic Neuralgia US Market (USD Millions), (2013-2015)
• Table 10: Postherpetic Neuralgia US Market (USD Millions), (2016-2023)
• Table 11: Postherpetic Neuralgia Germany Market (USD Millions), (2013-2015)
• Table 12: Postherpetic Neuralgia Germany Market (USD Millions), (2016-2023)
• Table 13: Postherpetic Neuralgia United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Postherpetic Neuralgia United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Postherpetic Neuralgia France Market (USD Millions), (2013-2015)
• Table 16: Postherpetic Neuralgia France Market (USD Millions), (2016-2023)
• Table 17: Postherpetic Neuralgia Italy Market (USD Millions), (2013-2015)
• Table 18: Postherpetic Neuralgia Italy Market (USD Millions), (2016-2023)
• Table 19: Postherpetic Neuralgia Spain Market (USD Millions), (2013-2015)
• Table 20: Postherpetic Neuralgia Spain Market (USD Millions), (2016-2023)
• Table 21: Postherpetic Neuralgia Japan Market (USD Millions), (2013-2015)
• Table 22: Postherpetic Neuralgia Japan Market (USD Millions), (2016-2023)
• Table 23: Postherpetic Neuralgia ROW Market (USD Millions), (2013-2015)
• Table 24: Postherpetic Neuralgia ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Postherpetic Neuralgia Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Postherpetic Neuralgia (2013-2023)
• Figure 3: Postherpetic Neuralgia Global Market (USD Millions), (2013-2015)
• Figure 4: Postherpetic Neuralgia Global Market (USD Millions), (2016-2023)
• Figure 5: Postherpetic Neuralgia US Market (USD Millions), (2013-2015)
• Figure 6: Postherpetic Neuralgia US Market (USD Millions), (2016-2023)
• Figure 7: Postherpetic Neuralgia Germany Market (USD Millions), (2013-2015)
• Figure 8: Postherpetic Neuralgia Germany Market (USD Millions), (2016-2023)
• Figure 9: Postherpetic Neuralgia United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Postherpetic Neuralgia United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Postherpetic Neuralgia France Market (USD Millions), (2013-2015)
• Figure 12: Postherpetic Neuralgia France Market (USD Millions), (2016-2023)
• Figure 13: Postherpetic Neuralgia Italy Market (USD Millions), (2013-2015)
• Figure 14: Postherpetic Neuralgia Italy Market (USD Millions), (2016-2023)
• Figure 15: Postherpetic Neuralgia Spain Market (USD Millions), (2013-2015)
• Figure 16: Postherpetic Neuralgia Spain Market (USD Millions), (2016-2023)
• Figure 17: Postherpetic Neuralgia Japan Market (USD Millions), (2013-2015)
• Figure 18: Postherpetic Neuralgia Japan Market (USD Millions), (2015-2023)
• Figure 19: Postherpetic Neuralgia ROW Market (USD Millions), (2013-2015)
• Figure 20: Postherpetic Neuralgia ROW Market (USD Millions), (2016-2023)
【掲載企業】
• Aestus Therapeutics Inc.
• ContraVir Pharmaceuticals Inc.
• Daewoong Pharmaceutical Co. Ltd.
• Daiichi Sankyo Company Limited
• Immune Pharmaceuticals Inc.
• Kineta Inc.
• Merck & Co. Inc.
• Pfizer Inc.
• Phosphagenics Limited
• Purdue Pharma L.P.
• Relmada Therapeutics Inc.
• Scilex Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.
• Toray Industries Inc.
【レポートのキーワード】
ヘルペス後神経痛
【免責事項】
https://www.marketreport.jp/reports-disclaimer